U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

AUTOLOGOUS CULTURED CHONDROCYTES

MORE DETAILS

D5P3K3V822

structurally diverse
Status:
US Approved Rx (2016)
Source:
BLA125603
(2016)
Source URL:
https://www.fda.gov/media/113210/download
First approved in 1997
Source:
CARTICEL SM SERVICE by VERICEL CORPORATION
Source URL:
https://www.fda.gov/media/113210/download
Class:
STRUCTURALLY DIVERSE

AZFICEL-T

MORE DETAILS

022461SR75

structurally diverse
Status:
US Previously Marketed
Source:
LAVIV by FIBROCELL TECHNOLOGIES INC
(1998)
Source URL:
https://www.fda.gov/media/113210/download
First approved in 1998
Source:
LAVIV by FIBROCELL TECHNOLOGIES INC
Source URL:
https://www.fda.gov/media/113210/download
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966